ABBOTT LABORATORIES·4

Feb 23, 6:56 PM ET

Karam Sammy 4

4 · ABBOTT LABORATORIES · Filed Feb 23, 2021

Insider Transaction Report

Form 4
Period: 2021-02-19
Karam Sammy
Senior Vice President
Transactions
  • Award

    Option (right to buy)

    2021-02-19+53,32653,326 total
    Exercise: $124.04From: 2022-02-19Exp: 2031-02-18Common Shares (53,326 underlying)
Footnotes (1)
  • [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 17,775 on February 19, 2022, 17,775 on February 19, 2023, and 17,776 on February 19, 2024.

Documents

1 file
  • 4
    form4-02232021_030246.xmlPrimary